San Antonio, October 19, 2015—For patients with locally advanced esophageal cancer that has spread to the lymph nodes, radiation therapy (RT) that targets only the involved lymph nodes regions results in less toxicity without causing a statistically significant difference in loco-regional lymph nodal recurrence, distant failure and overall survival rates, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 57th Annual Meeting.
http://www.dotmed.com/news/story/27551
Benefits of involved field irradiation therapy for locally advanced esophageal cancer